Radiation Dose in the Uterine Perforation by Tandem in 3-Dimensional Cervical Cancer Brachytherapy

• Published in: Medical dosimetry : official journal of the American Association of Medical Dosimetrists Vol. 44; no. 4; p. e59
• Main Authors: Tsai, Yu-Lun, Yu, Pei-Chieh, Nien, Hsin-Hua, Sung, Shih-Yu, Kuan, Yi-Hsuan, Wu, Ching-Jung
• Format: Journal Article
• Language: English
• Published: United States 2019
• Subjects: Aged; Brachytherapy - adverse effects; Female; Humans; Imaging, Three-Dimensional; Middle Aged; Organs at Risk - radiation effects; Patient Positioning; Radiation Dosage; Radiation Injuries - etiology; Radiometry; Radiotherapy, Image-Guided - methods; Risk Factors; Tomography, X-Ray Computed; Uterine Cervical Neoplasms - radiotherapy; Uterine Perforation - etiology; Radiation dose; 3D brachytherapy; Cervical cancer; Uterine perforation
• ISSN: 1873-4022
• DOI: 10.1016/j.meddos.2019.01.006

Cervical cancer patients may sometimes experience different types of uterine perforation by a tandem during brachytherapy. The purpose of this study was to address possibly different management strategies regarding different tandem positions from a dosimetry aspect by evaluating radiation doses delivered to organs-at-risk (OAR) in order to help medical professionals handle different types of uterine perforation. Images and dosimetry data in cervical cancer brachytherapy with uterine perforation were reviewed. Uterine perforation was classified into anterior and posterior perforation according to their tandem positions. Radiation doses received by OAR, including D and D of the bladder, rectum, and sigmoid colon, were statistically compared with nonperforation. The doses of high-risk clinical target volume (HR-CTV) of cervical tumor and bilateral point A were also compared in order to assure that the plans had not compromised the treatment efficacy. A total of 21 applications were assessed, including 5 with anterior perforation, 4 with posterior perforation, and 12 without perforation. In anterior perforation, the bladder was the only organ that received a significantly increased dose about 30% at D and D . However, in posterior perforation, multiple OAR received significantly excessive doses: approximately 30% for the bladder, 37% for the rectum, and 100% for the sigmoid colon. The OAR dose assessment was based on a statistically equivalent cervical tumor dose. Different management strategies are possible for anterior vs posterior perforation during brachytherapy due to different detrimental extents on OAR dosimetry. The bladder warrants more attention in anterior perforation, without compromising target coverage in treatment planning. On the other hand, repositioning may be considered in posterior perforation due to relatively massive OAR detriments. This concept is a new one and is given for the first time.